Cas9(S. aureus)(6H4) Mouse Monoclonal Antibody (Alexa Fluor®555 Conjugate)#47052,Cell Signaling Technology (CST),47052

Cas9(S. aureus)(6H4) Mouse Monoclonal Antibody (Alexa Fluor®555 Conjugate) recognizes endogenous levels of total Cas9 (S. aureus)protein. This antibody conjugate does not cross-react with Cas9 (S. pyogenes),AsCpf1 (StrainBV3L6), and FnCpf1 (StrainU112) proteins.

Host

Mouse

Reactivity

All Species Expected

Application

Immunofluorescence (Immunocytochemistry): 1:50

Platform ID

BAB379318513

Cell Signaling Technology (CST)

Headquarters

3 Trask Lane Danvers, MA 01923

Contact

Tel: 877-616-2355,978-867-2388
Fax: 877-616-2355

Product Specifications
Scientific Background
Synonyms

Specifications

NameCas9(S. aureus)(6H4) Mouse Monoclonal Antibody (Alexa Fluor®555 Conjugate)#47052
Cat. No.47052
Accession NumberJ7RUA5
HostMouse
SensitivityTransfected Only
ReactivityAll Species Expected
ApplicationImmunofluorescence (Immunocytochemistry): 1:50
ImmunogenIgG2b
FormulationSupplied in PBS (pH 7.2), less than 0.1% sodium azide and 2 mg/ml BSA. Store at 4°C.Do not aliquot the antibody. Protect from light. Do not freeze.
StorageSupplied in PBS (pH 7.2), less than 0.1% sodium azide and 2 mg/ml BSA. Store at 4°C.Do not aliquot the antibody. Protect from light. Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

The CRISPR associated protein 9 (Cas9) is an RNA-guided DNA nuclease and part of the CRISPR antiviral immunity system that provides adaptive immunity against extra chromosomal genetic material (1). The CRISPR antiviral mechanism of action involves three steps: (i), acquisition of foreign DNA by host bacterium; (ii), synthesis and maturation of CRISPR RNA (crRNA), followed by the formation of RNA-Cas nuclease protein complexes; and (iii), target interference through recognition of foreign DNA by the complex and its cleavage by Cas nuclease activity (2). The type II CRISPR/Cas antiviral immunity system provides a powerful tool for precise genome editing and has potential for specific gene regulation and therapeutic applications (3). The Cas9 protein and a guide RNA consisting of a fusion between a crRNA and a trans-activating crRNA (tracrRNA) must be introduced or expressed in a cell. A 20-nucleotide sequence at the 5' end of the guide RNA directs Cas9 to a specific DNA target site. As a result, Cas9 can be "programmed" to cut various DNA sites bothin vitroand in cells and organisms. CRISPR/Cas9 genome editing tools have been used in many organisms, including mouse and human cells (4,5). Research studies demonstrate that CRISPR can be used to generate mutant alleles or reporter genes in rodents and primate embryonic stem cells (6-8).Cas9 (S. aureus) is a Cas9 ortholog that is smaller, but as efficient, as the more commonly used Cas9 ortholog, Cas9 (S. pyogenes) (9).Horvath, P. and Barrangou, R. (2010)Science327, 167-70.Wiedenheft, B. et al. (2012)Nature482, 331-8.Singh, P. et al. (2015)Genetics199, 1-15.Cong, L. et al. (2013)Science339, 819-23.Mali, P. et al. (2013)Science339, 823-6.Li, D. et al. (2013)Nat Biotechnol31, 681-3.Shen, B. et al. (2013)Cell Res23, 720-3.Niu, Y. et al. (2014)Cell156, 836-43.Ran, F.A. et al. (2015)Nature520, 186-91.Alternate NamesCas9 iso2; CRISPR-associated endonuclease Cas9

Synonyms

Cas9 iso2; CRISPR-associated endonuclease Cas9

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.